US Ebola case boosts biotechs with treatments By: CNBC.com News October 01, 2014 at 06:07 AM EDT Sentiment in U.S. stock futures overall was dampened early Wednesday after the U.S. confirmed its first case of Ebola. But biotech stocks were stronger. Read More >> Related Stocks: Acuity Brands Inc JPMorgan Chase & Co Sarepta Therapeutics Sentinelone Inc Cl A